StockWatch
·

Genpharmasec Ltd

BSE: 531592

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-8.0114.4836.9659.45Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
-10.71-1.008.7118.42Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue44.78-13.3%51.66+43.5%36.01+14.1%31.56+160.6%12.11-10.6%13.56+62.6%8.34+44.5%5.77
Other Income0.97-40.0%1.62+13.2%1.43+42.9%1.00+21.6%0.82-22.5%1.06+13.9%0.93+8.5%0.86
Total Income45.76-14.1%53.28+42.3%37.44+15.0%32.56+151.7%12.94-11.5%14.62+57.7%9.27+39.8%6.63
EXPENSES
Expenditure43.66-13.4%50.42+36.5%36.95+18.5%31.18+177.7%11.23-23.4%14.65+94.6%7.53+34.6%5.60
Tax0.53-3.1%0.54+302.8%-0.27-147.6%0.56+285.2%0.15-23.4%0.19-68.6%0.61+1691.2%0.03
PROFIT
PBT2.10-26.7%2.86+487.2%0.49-64.7%1.38-19.1%1.71+4918.9%-0.04-102.0%1.74+68.5%1.03
Net Profit1.57-32.3%2.32+206.6%0.76-7.3%0.82-47.7%1.56+787.5%-0.23-120.1%1.13+13.0%1.00
KEY METRICS
OPM %3.02%-0.05pp3.07%+4.95pp-1.88%-3.48pp1.60%-6.68pp8.28%+15.63pp-7.35%-15.20pp7.85%+6.31pp1.54%
NPM %3.43%-0.92pp4.35%+2.33pp2.02%-0.49pp2.51%-9.54pp12.05%+13.60pp-1.55%-13.72pp12.17%-2.89pp15.06%
EPS0.03-25.0%0.04+300.0%0.01+0.0%0.01-66.7%0.03+200.0%0.01-50.0%0.02+0.0%0.02

Corporate Events

Board MeetingGENPHARMA
2026
29Sep

Board Meeting

The company will hold its 34th Annual General Meeting on Sep…

BSE Filing
Board MeetingGENPHARMA
2026
2Sep

Board Meeting

The Board Meeting is scheduled to consider and approve the A…

BSE Filing
Board MeetingGENPHARMA
2026
11Aug

Board Meeting

The Board of Directors will consider and approve Un-audited …

BSE Filing
Board MeetingGENPHARMA
2025
2Sep

Board Meeting

Fix the Day, Date, Time and Mode of Annual General Meeting, …

BSE Filing
Board MeetingGENPHARMA
2024
27Jun

Board Meeting

To Fix the Day, Date, Time and Mode of Annual General Meetin…

BSE Filing
Board MeetingGENPHARMA
2024
24May

Board Meeting

Consider and approve:</br>1. The Audited Standalone & Consol…

BSE Filing